Search - tctmd.com

Displaying 121 - 140 of 280

Sort: Relevancy | Date

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Yael L. Maxwell

September 03, 2019

News Conference News ESC 2019

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Shelley Wood

September 03, 2019

PURE Sturdy: New insights into anthropometrics and cardiovascular outcomes in 142,000 adults from 21 countries followed for 9 years

Presentation ESC 2019

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

Presenter: Darryl P. Leong

September 02, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

Presentation ESC 2019

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin

Todd Neale

September 01, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation ESC 2019

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Caitlin E. Cox

September 07, 2018

Advertisement

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content